Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Grant Funds Schizophrenia Study
Uncategorized

Grant Funds Schizophrenia Study

By medwebJan 1, 2006
Share
Facebook Twitter Email

December 27, 2005

Grant Funds Schizophrenia Study

CHICAGO—D. James Surmeier, PhD, Nathan Smith Davis Professor and chair of physiology at Northwestern University’s Feinberg School of Medicine, has received a five-year, $1.5 million grant from the National Institute of Mental Health to study how the brain adapts to drugs used to treat schizophrenia.

The award is part of a larger $12 million grant to form a multi-institutional Silvio O. Conte Center for the Neuroscience of Mental Disorders. The center is headed by Nobel Prize Laureate Paul Greengard of Rockefeller University.

Dr. Surmeier and his laboratory group will characterize how neurons in the prefrontal cortex and striatum adapt to neuroleptics, drugs used in the treatment of schizophrenia.

Using a broad combination of optical, electrophysiological, and molecular approaches, his group will focus on how the typical and atypical neuroleptics reshape the way in which cortical and striatal neurons process synaptic signals underlying cognition.

Dr. Surmeier’s research team draws not only on the resources of the Feinberg School but also those of Nelson Spruston, PhD, associate professor of neurobiology and physiology, Weinberg College of Arts and Sciences at Northwestern University, a renowned leader in the neurobiology of synaptic processing.

Share. Facebook Twitter Email

Related Posts

Lurie Cancer Center Receives Merit Extension from NCI

Oct 20, 2021

Drug Combination May Reduce Risk of Leukemia Relapse

Mar 26, 2020

Rewriting the Role of a Transcription Factor

Mar 19, 2020

Comments are closed.

Latest News

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023

Humans are Not Just Big Mice: Identifying Science’s Muscle-Scaling Problem

Mar 20, 2023

AOA Honors New Members

Mar 20, 2023

Celebrating Feinberg’s 2023 Match Day

Mar 17, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230315_NM036
20230315_NM046
20230315_NM134
20230315_NM205
20230315_NM206
20230315_NM132
20230315_NM130
20230315_NM082
20230315_NM063
20230315_NM058
20230315_NM030
20230315_NM038

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.